UroLift and TURP treat the same problem with very different goals. UroLift uses permanent implants to retract obstructing prostate tissue, so recovery is fast and ejaculation is usually preserved. TURP removes obstructing tissue and therefore gives greater improvement in urinary flow and symptoms for many men, but it requires anaesthesia, a catheter and a longer healing period and commonly causes retrograde ejaculation. UroLift is usually best for carefully selected smaller-to-moderate glands without unfavourable median-lobe anatomy; TURP remains a more definitive option when obstruction is substantial or complications have developed.

Quick comparison

What UroLift means

UroLift, or prostatic urethral lift, is a non-ablative procedure. The urinary channel is widened by tensioning the enlarged lateral lobes away from the urethra. There is no tissue resection and no thermal injury.

What TURP means

TURP is a tissue-removing operation performed through the urethra. The surgeon cuts the central adenomatous tissue into chips and controls bleeding, leaving a wider prostatic channel. Bipolar TURP is now widely used because saline irrigation improves fluid safety.

When UroLift may be preferred

• Rapid return to routine activity is important.
• Preserving antegrade ejaculation is a high priority.
• Prostate size and lateral-lobe anatomy are suitable.
• The patient accepts a higher chance of needing another BPH treatment later.

When TURP may be preferred

• Obstruction is severe or urinary flow is very poor.
• There is recurrent retention, bladder stone disease or other BPH complications.
• Maximum symptom and flow improvement are the priorities.
• The patient accepts likely ejaculatory change.

Benefits and limitations that matter most

UroLift is not simply a smaller TURP. It gives up some de-obstructive power and durability to protect recovery and sexual function. TURP gives up some recovery speed and ejaculation preservation to achieve a larger tissue-removing effect. A patient with repeated retention may gain little by choosing the smaller procedure if he subsequently needs TURP anyway.

What current guidelines say about UroLift selection

The 2026 EAU guideline strongly recommends UroLift for men who want to preserve ejaculation when the prostate is under 70 mL and there is no obstructing middle lobe. The same guideline specifically advises patients that retreatment is higher after UroLift than after TURP. That selection boundary is clinically important: a technically possible implant is not automatically the best implant.

Recovery differences

After UroLift, most adverse symptoms are irritative and settle within days to a few weeks. After TURP, catheterisation, bleeding and internal wound healing make recovery longer; activity is usually increased gradually over several weeks. TURP can produce urgency and frequency during healing even though the urinary channel is already wider.

When the faster recovery is worth the trade-off

For a man with a 45-60 mL prostate, favourable lateral lobes, a small residual urine and no retention, UroLift can be attractive if preserving ejaculation and returning to work quickly matter more than maximising flow. Change the history to repeated retention, a bladder stone or a very high residual, and the balance usually moves toward TURP or another tissue-removing operation because durability and de-obstruction become more important than avoiding a catheter for a few days.

• UroLift works best when the anatomy fits its evidence-based selection criteria rather than simply because the gland is “not very big.”
• TURP is more appropriate when the patient needs a reliably wide channel and accepts the likelihood of ejaculatory change.
• Permanent UroLift implants should be part of future procedure planning if another prostate operation is later required.
• If very large prostate size or severe obstruction is present, HoLEP or another enucleation may be a more relevant comparator than either UroLift or TURP.

What to bring for consultation

• Ultrasound with prostate volume and post-void residual.
• Uroflowmetry if available.
• Urine routine/culture and serum creatinine.
• PSA report when clinically relevant.
• Medication list, especially alpha blockers, 5-alpha-reductase inhibitors and blood thinners.
• Records of catheterisation, retention or previous prostate procedures.

FAQs

Related reading

• UroLift for Enlarged Prostate
• TURP Recovery: Week-by-Week Patient Guide
• Which Prostate Treatments Can Preserve Ejaculation?
• Which Prostate Surgery Is Best for Me? TURP, HoLEP or Other Options
• Urologist in Latur

References

• European Association of Urology. EAU Guidelines on the Management of Non-neurogenic Male LUTS: Disease Management, 2026 https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts/chapter/disease-management
• American Urological Association. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia Guideline https://www.auanet.org/guidelines-and-quality/guidelines/bph-guideline
• National Institute for Health and Care Excellence. UroLift guidance (HTG578) https://www.nice.org.uk/guidance/htg578
• British Association of Urological Surgeons. Prostate procedures: patient information https://www.baus.org.uk/patients/information_leaflets/category/8/prostate_procedures